220290-68-6

Usage

Uses

Used in Pharmaceutical Industry:
2-Oxa-6-azaspiro[3.4]octane is used as a building block for the synthesis of azaspirocycle or azetidine substituted 4-anilinoquinazoline derivatives. These derivatives exhibit epidermal growth factor receptor (EGFR) inhibitory activities, making them valuable in the development of targeted therapies for cancer treatment.

Downstream Products

• 1578245-21-2 N-(2-ethoxy-4-(1-methyl-1H-pyrazol-4-yl)phenyl)-8-(2-oxa-6-azaspiro[3.4]octan-6-yl)pyrido[3,4-d]pyrimidin-2-amine 
• 1426257-56-8 2-[(S)-4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl]-1-(2-oxa-6-azaspiro[3.4]oct-6-yl)ethan-1-one 
• 1445860-68-3 4-(3'-chloro-4'-fluorophenylamino)-6-[3-(2-oxa-6-azaspiro[3.4]octane-6-yl)propoxy]-7-methoxyquinazoline 
• 1408284-59-2 6-(4-fluoro-phenyl)-3-{3-methoxy-4-[2-(2-oxa-6-aza-spiro[3.4]oct-6-yl)-ethoxy]-phenyl}-3H-thieno[3,2-d]pyrimidin-4-one 

Relevant academic research and scientific papers

Spirocyclic oxetanes: Synthesis and properties

(Chemical Presented) Wormholes through chemical space: Spirocyclic oxetanes are described as analogues of morpholine and also as topological siblings of their carbonyl counterparts. They are particularly promising in terms of both their physicochemical properties and the ease with which they can be grafted onto molecular structures. The data collected highlight oxetanes as both the hydrophilic sister of a gem-dimethyl unit and the carbonyl group's lipophilic brother.